RxDoctor Payments Data

Betsy Grunch, MD

Neurological Surgery · Gainesville, GANPI 1265606644

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (43.9%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 53 manufacturers reported payments, led by Hyhte Holdings Inc. at 35.1% of the total. Among neurological surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,085,599in general payments, 2019–2025

Across 731 payments — averaging $1485.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hyhte Holdings Inc.$381K
  • Spineology Inc.$190K
  • Acadia Pharmaceuticals Inc$112K
  • Choice Spine, LLC$109K
  • Intrinsic Therapeutics$52K
  • Nevro Corp.$49K
  • plus $193K from 47 others
$91,907in research payments, 2019–2025

Across 28 payments — averaging $3282.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orthofix Medical, Inc.$49K
  • Intrinsic Therapeutics$26K
  • Surgalign Spine Technologies, Inc.$10K
  • Centinel Spine, LLC$7K
$122,588in ownership & investment interests, 2019–2025

Across 7 payments — averaging $17,513 each. An ownership or investment interest held by the physician or an immediate family member.

  • Phasor Health, LLC$122K
  • Spineology Inc.$272

What the payments were for

  • Royalty or licence$476,35044%
  • Consulting fees$322,34430%
  • Speaking & faculty fees$160,55315%
  • Travel & lodging$94,2929%
  • Food & beverage$31,4323%
  • Education$1260%
  • Gifts$1540%
  • Entertainment$3480%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,085,599 in reported general payments places this provider in the 95th percentile of 201 neurological surgery providers in Georgia.

See all neurological surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$391,815
Medicare patients
550
Services billed
2,545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen135$1,527
Gabapentin80$1,077
Oxycodone Hcl103$868
Cyclobenzaprine Hcl79$669
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen67$584
Pregabalin35$559
Methocarbamol75$539
Mupirocin71$495
Tizanidine Hcl31$151
Methylprednisolone22$117
Tramadol Hcl31$92
Meloxicam18$71
Ondansetron Hcl11$37

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Gainesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →